[Differential malignant lymphoproliferative syndrome (LPS) diagnosis with flow cytometry: a study of 100 patients]

N Cardile1, G Sabo, P Butsch

  • 1Abteilung für Hämatologie, Institut Dr. Viollier, Basel.

Praxis
|February 25, 2000
PubMed

Insights

Flow cytometry accurately diagnoses 100 patients with lymphoproliferative disorders (LPD). Immunophenotypic findings aid in distinguishing B-cell chronic lymphocytic leukemia, hairy cell leukemia, and B-cell Non-Hodgkin lymphomas for targeted therapy.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Context:

  • Flow cytometry is crucial for diagnosing chronic lymphoproliferative disorders (LPD).
  • Distinguishing between distinct LPD entities is vital for effective therapeutic decisions.
  • This study analyzes immunophenotypic findings in 100 newly diagnosed LPD patients.

Purpose:

  • To report the immunophenotypic findings of 100 patients with newly diagnosed LPD using two-color flow cytometry.
  • To detail the application of a >15 monoclonal antibody panel for LPD diagnosis.
  • To correlate clinical presentations with specific LPD diagnoses.

Summary:

  • B-cell chronic lymphocytic leukemia (B-CLL) was identified in 74 patients (CD5+, CD23+, FMC7-).
  • Hairy cell leukemia (HCL) and B-cell Non-Hodgkin lymphoma (B-NHL) were diagnosed in 6 and 13 patients, respectively.
  • T-cell LPDs were less frequent (4 patients), including Sézary syndrome and T gamma lymphoproliferation.

Impact:

  • Immunophenotypic diagnosis was confirmed histologically or molecularly in 17 patients with characteristic marker profiles.
  • Clinical features like lymphadenopathy suggested mantle cell lymphoma, while splenomegaly indicated HCL.
  • Early diagnosis of B-CLL (94%) allowed for conserved hematopoiesis, with 32% of LPDs detected via routine hematogram.